Oxford Biomedica PLC — Investor Relations & Filings
Oxford Biomedica (OXB) is a global contract development and manufacturing organization (CDMO) specializing in cell and gene therapy. A pioneer in the field, the company has extensive experience in viral vectors, the enabling technology for many advanced therapies. OXB provides end-to-end services to pharmaceutical and biotechnology partners, supporting programs from preclinical development through to commercial launch. Its core expertise includes the development and GMP manufacturing of various vector types, including lentivirus, adeno-associated virus (AAV), and adenovirus. The company offers proprietary technologies like its LentiVector™ platform, the first commercially approved lentiviral system, and its inAAVate™ platform for AAV, in addition to tech-transfer capabilities.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| PDMR Dealing | 2026-05-19 | English | |
| PDMR Dealing | 2026-05-13 | English | |
| Print of AGM Resolutions | 2026-05-11 | English | |
| AGM Minutes | 2026-05-07 | English | |
| Result of AGM | 2026-05-07 | English | |
| Total Voting Rights | 2026-05-01 | English |
Browse filings by year
17 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 46530409 | PDMR Dealing | 2026-05-19 | English | ||
| 45541627 | PDMR Dealing | 2026-05-13 | English | ||
| 44914653 | Print of AGM Resolutions | 2026-05-11 | English | ||
| 43633533 | AGM Minutes | 2026-05-07 | English | ||
| 43197184 | Result of AGM | 2026-05-07 | English | ||
| 39399113 | Total Voting Rights | 2026-05-01 | English | ||
| 39034920 | Admission to Trading | 2026-04-30 | English | ||
| 37376856 | Admission to Trading Application | 2026-04-27 | English | ||
| 34392469 | Launch of viral vector fast-track offering | 2026-04-13 | English | ||
| 33897356 | Grant of Awards | 2026-04-08 | English | ||
| 33128279 | Total Voting Rights | 2026-04-01 | English | ||
| 33090029 | Annual financial and audit reports | 2026-03-30 | English | ||
| 33090024 | Annual financial and audit reports | 2026-03-30 | English | ||
| 33090019 | 2026 Annual General Meeting notification | 2026-03-30 | English | ||
| 33089974 | 2026 Notice of AGM | 2026-03-30 | English | ||
Financials
We couldn't load the financials
No data available yet
We have extracted financials for Oxford Biomedica PLC, but not for this combination of statement and period. Try a different combination.
Swipe the table to view all periods, or rotate your phone for a wider view.
| Line item | ! |
|---|---|
| Definition not yet available — coming soon. |
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
CS Medica A/S
Develops and manufactures OTC medical devices and cosmetics…
|
CSMED | DK | Manufacturing |
|
CSPC Innovation Pharmaceutical Co.,Ltd.
Global supplier of caffeine, pharmaceutical ingredients, an…
|
300765 | CN | Manufacturing |
|
CSPC Pharmaceutical Group Limited
R&D, manufacturing, and sale of innovative finished and bul…
|
1093 | HK | Manufacturing |
|
CStone Pharmaceuticals
Innovation-driven biopharma focused on R&D and commercializ…
|
2616 | KY | Manufacturing |
|
CTC BIO, INC.
Develops and manufactures human and animal health products …
|
060590 | KR | Manufacturing |
|
Cue Biopharma, Inc.
Develops biologics to selectively modulate the immune syste…
|
CUE | US | Manufacturing |
|
Cullinan Therapeutics, Inc.
A clinical-stage biopharmaceutical company developing thera…
|
CGEM | US | Manufacturing |
|
CUMBERLAND PHARMACEUTICALS INC
Acquires, develops, and commercializes branded drugs for ho…
|
CPIX | US | Manufacturing |
|
Cuorips Inc.
Develops iPS cell-derived therapies and provides cell proce…
|
4894 | JP | Manufacturing |
|
Cuprina Holdings (Cayman) LTD
Biomedical firm developing wound care biotherapy and cosmec…
|
CUPR | US | Manufacturing |
Oxford Biomedica PLC via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/5190/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=5190 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=5190 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=5190 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 5190}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Oxford Biomedica PLC (id: 5190)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.